Ionescu, D.N.; Stockley, T.L.; Banerji, S.; Couture, C.; Mather, C.A.; Xu, Z.; Blais, N.; Cheema, P.K.; Chu, Q.S.-C.; Melosky, B.;
et al. Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer. Curr. Oncol. 2022, 29, 4981-4997.
https://doi.org/10.3390/curroncol29070396
AMA Style
Ionescu DN, Stockley TL, Banerji S, Couture C, Mather CA, Xu Z, Blais N, Cheema PK, Chu QS-C, Melosky B,
et al. Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer. Current Oncology. 2022; 29(7):4981-4997.
https://doi.org/10.3390/curroncol29070396
Chicago/Turabian Style
Ionescu, Diana N., Tracy L. Stockley, Shantanu Banerji, Christian Couture, Cheryl A. Mather, Zhaolin Xu, Normand Blais, Parneet K. Cheema, Quincy S.-C. Chu, Barbara Melosky,
and et al. 2022. "Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer" Current Oncology 29, no. 7: 4981-4997.
https://doi.org/10.3390/curroncol29070396
APA Style
Ionescu, D. N., Stockley, T. L., Banerji, S., Couture, C., Mather, C. A., Xu, Z., Blais, N., Cheema, P. K., Chu, Q. S.-C., Melosky, B., & Leighl, N. B.
(2022). Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer. Current Oncology, 29(7), 4981-4997.
https://doi.org/10.3390/curroncol29070396